CVS

Some Facts on CVS Health Shares

Large-cap Consumer Staples company CVS Health has logged a -0.7% change today on a trading volume of 139,430. The average volume for the stock is 9,001,762.

CVS Health Corporation provides health services in the United States. Based in Woonsocket, United States the company has 219,000 full time employees and a market cap of $88,985,796,608. CVS Health currently offers its equity investors a dividend that yields 3.3% per year.

The company is now trading -23.48% away from its average analyst target price of $90.54 per share. The 23 analysts following the stock have set target prices ranging from $76.0 to $110.0, and on average give CVS Health a rating of buy.

Over the last 12 months CVS shares have declined by -20.0%, which represents a difference of -37.0% when compared to the S&P 500. The stock's 52 week high is $104.83 per share and its 52 week low is $64.62. With its net margins declining an average -1.7% over the last 6 years, CVS Health declining profitability gives us reason to believe its stock price will continue to underwhelm.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2022-02-09 292,111,000 7,910,000 3 0.0
2021-02-16 268,706,000 7,179,000 3 0.0
2020-02-18 256,776,000 6,634,000 3 inf
2019-02-28 194,579,000 -594,000 0 -100.0
2018-02-14 184,786,000 6,622,000 4 33.33
2017-02-09 177,546,000 5,317,000 3
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

ON FOCUS